131 related articles for article (PubMed ID: 36177902)
1. The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Cencini E; Tucci A; Puccini B; Cavallo F; Luminari S; Usai SV; Fabbri A; Pennese E; Marino D; Zilioli VR; Balzarotti M; Petrucci L; Tafuri A; Arcari A; Botto B; Zanni M; Hohaus S; Sartori R; Merli M; Gini G; Al Essa W; Musurca G; Tani M; Nassi L; Daffini R; Mammi C; Marcheselli L; Bocchia M; Spina M; Merli F
Hematol Oncol; 2023 Feb; 41(1):78-87. PubMed ID: 36177902
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Tucci A; Merli F; Fabbri A; Marcheselli L; Pagani C; Puccini B; Marino D; Zanni M; Pennese E; Flenghi L; Arcari A; Botto B; Celli M; Mammi C; Re A; Campostrini G; Tafuri A; Zilioli VR; Cencini E; Sartori R; Bottelli C; Merli M; Petrucci L; Gini G; Balzarotti M; Cavallo F; Musuraca G; Luminari S; Rossi G; Spina M
Haematologica; 2023 Apr; 108(4):1083-1091. PubMed ID: 36384247
[TBL] [Abstract][Full Text] [Related]
3. Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Tucci A; Arcari A; Rigacci L; Hawkes E; Chiattone CS; Cavallo F; Cabras G; Alvarez I; Fabbri A; Re A; Puccini B; Barraclough A; Delamain MT; Ferrero S; Usai SV; Ferrari A; Cencini E; Pennese E; Zilioli VR; Marino D; Balzarotti M; Cox MC; Zanni M; Di Rocco A; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Nassi L; Musuraca G; Tani M; Bottelli C; Kovalchuk S; Re F; Flenghi L; Molinari A; Tarantini G; Chimienti E; Marcheselli L; Mammi C; Spina M
J Clin Oncol; 2021 Apr; 39(11):1214-1222. PubMed ID: 33577377
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
5. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.
Carson KR; Riedell P; Lynch R; Nabhan C; Wildes TM; Liu W; Ganti A; Roop R; Sanfilippo KM; O'Brian K; Liu J; Bartlett NL; Cashen A; Wagner-Johnston N; Fehniger TA; Colditz GA
J Geriatr Oncol; 2015 May; 6(3):211-8. PubMed ID: 25614297
[TBL] [Abstract][Full Text] [Related]
7. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.
Gobba S; Moccia AA; Gulden-Sala W; Conconi A; Diem S; Cascione L; Iacoboni G; Margiotta-Casaluci G; Aprile von Hohenstaufen K; Stathis A; Hitz F; Pinotti G; Gaidano G; Zucca E
Hematol Oncol; 2018 Feb; 36(1):84-92. PubMed ID: 28621491
[TBL] [Abstract][Full Text] [Related]
9. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.
Visco C; Chiappella A; Nassi L; Patti C; Ferrero S; Barbero D; Evangelista A; Spina M; Molinari A; Rigacci L; Tani M; Rocco AD; Pinotti G; Fabbri A; Zambello R; Finotto S; Gotti M; Carella AM; Salvi F; Pileri SA; Ladetto M; Ciccone G; Gaidano G; Ruggeri M; Martelli M; Vitolo U
Lancet Haematol; 2017 Jan; 4(1):e15-e23. PubMed ID: 27927586
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines.
Diamond A; Ayyappan S; Cao S; Tashtish N; Boughan K; Cooper B; Fu P; Caimi PF
Hematol Oncol; 2022 Oct; 40(4):626-636. PubMed ID: 35644011
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of clinical characteristics, treatment and survival of elderly patients with large diffuse B-cell lymphoma].
Li CY; Yang P; Dong F; Tian L; Wan W; Zhao W; Li QH; Pang M; Zhen JF; Jing HM
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3296-3302. PubMed ID: 33202490
[No Abstract] [Full Text] [Related]
12. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
Xu PP; Fu D; Li JY; Hu JD; Wang X; Zhou JF; Yu H; Zhao X; Huang YH; Jiang L; Liu F; Su LP; Chen ZW; Zeng QS; Chen JP; Fang MY; Ma J; Liu T; Song YP; Yu K; Li Y; Qiu LG; Chen XQ; Gu J; Yan JS; Hou M; Huang HY; Wang L; Cheng S; Shen Y; Xiong H; Chen SJ; Zhao WL
Lancet Haematol; 2019 Jun; 6(6):e328-e337. PubMed ID: 31126528
[TBL] [Abstract][Full Text] [Related]
13. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.
Merli M; Visco C; Spina M; Luminari S; Ferretti VV; Gotti M; Rattotti S; Fiaccadori V; Rusconi C; Targhetta C; Stelitano C; Levis A; Ambrosetti A; Rossi D; Rigacci L; D'Arco AM; Musto P; Chiappella A; Baldini L; Bonfichi M; Arcaini L
Haematologica; 2014 Mar; 99(3):489-96. PubMed ID: 24270404
[TBL] [Abstract][Full Text] [Related]
14. Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.
Merli F; Cavallo F; Salvi F; Tucci A; Musuraca G; Nassi L; Merli M; Tani M; Gini G; Ferrari A; Molinari AL; Liberati AM; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Zanni M; Mammi C; Luminari S
J Geriatr Oncol; 2020 Jan; 11(1):37-40. PubMed ID: 31296461
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Gini G; Tani M; Tucci A; Marcheselli L; Cesaretti M; Bellei M; Pascarella A; Ballerini F; Petrini M; Merli F; Olivieri A; Lanza F; Annibali O; Zilioli VR; Liberati AM; Tisi MC; Arcari A; Marino D; Musuraca G; Pavone V; Fabbri A; Pozzi S; Mannina D; Plenteda C; Celli M; Luminari S
Blood; 2023 Oct; 142(17):1438-1447. PubMed ID: 37418685
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma.
Ulu BU; Yiğenoğlu TN; Başcı S; Bakırtaş M; Şahin D; Darçın T; Yaman S; Bozan E; Seçilmiş S; Candır BA; Yıldız J; İskender D; Baysal NA; Çakar MK; Dal MS; Altuntaş F
Leuk Res; 2021 Nov; 110():106700. PubMed ID: 34481125
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.
Carella AM; de Souza CA; Luminari S; Marcheselli L; Chiappella A; di Rocco A; Cesaretti M; Rossi A; Rigacci L; Gaidano G; Merli F; Spina M; Stelitano C; Hohaus S; Barbui A; Puccini B; Miranda EC; Guida A; Federico M
Leuk Lymphoma; 2013 Jan; 54(1):53-7. PubMed ID: 22712840
[TBL] [Abstract][Full Text] [Related]
18. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Chiappella A; Tucci A; Castellino A; Pavone V; Baldi I; Carella AM; Orsucci L; Zanni M; Salvi F; Liberati AM; Gaidano G; Bottelli C; Rossini B; Perticone S; De Masi P; Ladetto M; Ciccone G; Palumbo A; Rossi G; Vitolo U;
Haematologica; 2013 Nov; 98(11):1732-8. PubMed ID: 23812930
[TBL] [Abstract][Full Text] [Related]
20. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
